Divis Laboratories

BSE : 532488 | NSE : DIVISLAB

Industry : Pharma Drugs | ISIN : INE361B01024 | FreeFloat : 50.00% | FnO : Yes | LotSize : 400


Intellectual Capital (IC)19,187.20
Net Worth (NW)7,808.69
Intrinsic Worth (IW)26,995.89
Market Cap (MC)60,497.63
Economic Value Added248.30
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)71.07%
IC Gross Margin (EBITDA/IC)13.09%
IC Net Margin (NPT/IC)9.04%
Knowledge Turnover (Sales/IC)0.33
Market to Intrinsic Value (MC/IW)2.24

As OfIntrinsic ValueMarket Price
30 Jun 2020Rs. 1,016.92Rs. 2,278.90
23 Oct 2020 - Rs. 3,068.85
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 3,123.14SellAvoid
KB > 50% : Yes50 DMA : Rs. 3,166.44
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Sep-17
S
890.20
923.79
310.79
276.86
276.11
206.78
206.40
Dec-17
S
1037.88
1054.89
343.15
305.76
305.50
224.66
224.29
Mar-18
S
1087.95
1136.12
434.67
395.88
396.05
261.60
263.38
Jun-18
S
995.31
1044.10
400.65
359.05
358.41
266.16
266.33
Sep-18
S
1285.00
1365.05
594.18
551.79
551.55
397.65
397.82
Dec-18
S
1342.92
1377.48
557.89
515.41
512.89
379.49
379.65
Mar-19
S
1256.43
1298.16
452.82
410.48
410.38
289.35
289.90
Jun-19
S
1139.92
1171.55
410.24
366.43
366.11
267.35
267.65
Sep-19
S
1403.92
1451.28
532.72
486.81
483.02
352.83
353.09
Dec-19
S
1390.49
1430.80
537.18
490.49
488.94
360.73
360.91
Mar-20
S
1376.24
1452.76
525.16
475.62
475.22
391.80
385.85
Jun-20
S
1709.96
1727.83
716.85
660.88
660.70
492.25
492.00
* C - Consolidated, S - Standalone